Bitcoin, cryptocurrency and worldwide payment system, is beginning to be cited in use cases beyond those just for currency. Blockchain, Bitcoin’s underlying...
Bitcoin, cryptocurrency and worldwide payment system, is beginning to be cited in use cases beyond those just for currency. Blockchain, Bitcoin’s underlying technology, has real potential to support clinical research by preventing fraud in scientific literature and regulatory submissions.
Bitcoin, cryptocurrency and worldwide payment system, is beginning to be cited in use cases beyond those just for currency. Blockchain, Bitcoin’s underlying technology, has real potential to support...
As of January 2018, the Clinical Data Interchange Standards Consortium (CDISC) will provide its Platinum members with access to its Shared Health and Research...
As of January 2018, the Clinical Data Interchange Standards Consortium (CDISC) will provide its Platinum members with access to its Shared Health and Research Electronic library (SHARE), a set of technologies the CDISC uses to develop and manage industry clinical data standards.
As of January 2018, the Clinical Data Interchange Standards Consortium (CDISC) will provide its Platinum members with access to its Shared Health and Research Electronic library (SHARE), a set...
Maintaining paper binders for clinical trial regulatory information is time consuming, requires on site updates, and lacks the flexibility for easy Sponsor...
Maintaining paper binders for clinical trial regulatory information is time consuming, requires on site updates, and lacks the flexibility for easy Sponsor access. Imagine electronic templates for this information, capable of being sent to an eTMF system automatically. This could significantly decrease the time it takes to get sites approved for study starts
Maintaining paper binders for clinical trial regulatory information is time consuming, requires on site updates, and lacks the flexibility for easy Sponsor access. Imagine electronic templates for...
Though not a new subject, eSource is still new to many investigator sites. Site teams have strong opinions about eSource, are still struggling to understand...
Though not a new subject, eSource is still new to many investigator sites. Site teams have strong opinions about eSource, are still struggling to understand what it is, and wondering if it requires investment. Many teams prefer to select and implement their own eSource system and favor providing input on eSource requirements to application providers.
Though not a new subject, eSource is still new to many investigator sites. Site teams have strong opinions about eSource, are still struggling to understand what it is, and wondering if it...
In anticipation of our upcoming Oracle Industry Connect event in New York City this spring, we are presenting Part 1 in a series of blog posts on life science...
In anticipation of our upcoming Oracle Industry Connect event in New York City this spring, we are presenting Part 1 in a series of blog posts on life science innovation in the Empire State. In the coming months, we’ll explore how advances in New York’s clinical pharma and biotechnology communities are driving bioscience forward and helping to save more lives.
In anticipation of our upcoming Oracle Industry Connect event in New York City this spring, we are presenting Part 1 in a series of blog posts on life science innovation in the Empire State. In...
Next week, the Galien Foundation hosts the Prix Galien awards at The American Museum of Natural History in Manhattan. The gala event -- including the...
Next week, the Galien Foundation hosts the Prix Galien awards at The American Museum of Natural History in Manhattan. The gala event -- including the ceremony, cocktail party, and dinner -- recognizes outstanding achievements in pharmaceuticals, biotechnology, and medical technology that improve the human condition. The award is considered the equivalent of the Nobel Prize in life sciences research. Ever wonder how Prix Galien got its name? The award honors Claudius...
Next week, the Galien Foundation hosts the Prix Galien awards at The American Museum of Natural History in Manhattan. The gala event -- including the ceremony, cocktail party, and dinner -- ...
A data model is quite simply a 'description of the structure' of stored data. For example, a clinical trial in Oracle Health Sciences InForm is described by an...
A data model is quite simply a 'description of the structure' of stored data. For example, a clinical trial in Oracle Health Sciences InForm is described by an InForm Clinical Trial Data Model. Data models are created by applications to store data and accessed by end users to manipulate data. Data models are important because they help end users to access data that is easily understandable, meaningful, and useable. For example, an Oracle Health Sciences InForm Clinical...
A data model is quite simply a 'description of the structure' of stored data. For example, a clinical trial in Oracle Health Sciences InForm is described by an InForm Clinical Trial Data Model. Data...
Many investigator sites cite the payment and reimbursement process as one of the most challenging in conducting clinical research. Many sites often are not...
Many investigator sites cite the payment and reimbursement process as one of the most challenging in conducting clinical research. Many sites often are not reimbursed in a timely manner, which can negatively impact the cash flow status of a site. Additionally, many research sites, outside academic research institutes, do not use a system for accounting. Rather they rely on spreadsheets or manual processes for reimbursements.
Many investigator sites cite the payment and reimbursement process as one of the most challenging in conducting clinical research. Many sites often are not reimbursed in a timely manner, which...
Clinical trials are critical to drug safety and efficacy because they supply patient based evidence that a drug can fight a disease. Yet many people have no...
Clinical trials are critical to drug safety and efficacy because they supply patient based evidence that a drug can fight a disease. Yet many people have no idea how these clinical studies work.
